James P. Kelly

2015 - Vanda Pharmaceuticals

In 2015, James P. Kelly earned a total compensation of $1.1M as Executive Vice President, Chief Financial Officer and Treasurer at Vanda Pharmaceuticals, a 7% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$210,000
Option Awards$302,400
Salary$375,000
Stock Awards$238,200
Other$19,526
Total$1,145,126

Kelly received $375K in salary, accounting for 33% of the total pay in 2015.

Kelly also received $210K in non-equity incentive plan, $302.4K in option awards, $238.2K in stock awards and $19.5K in other compensation.

Rankings

In 2015, James P. Kelly's compensation ranked 7,287th out of 13,638 executives tracked by ExecPay. In other words, Kelly earned more than 46.6% of executives.

ClassificationRankingPercentile
All
7,287
out of 13,638
47th
Division
Manufacturing
2,741
out of 5,187
47th
Major group
Chemicals And Allied Products
985
out of 1,857
47th
Industry group
Drugs
791
out of 1,531
48th
Industry
Pharmaceutical Preparations
616
out of 1,179
48th
Source: SEC filing on April 27, 2017.

Kelly's colleagues

We found five more compensation records of executives who worked with James P. Kelly at Vanda Pharmaceuticals in 2015.

2015

Richard Gulino

Vanda Pharmaceuticals

General Counsel

2015

Gian Reverberi

Vanda Pharmaceuticals

Senior Vice President, Chief Commercial Officer

2015

Mihael Polymeropoulos

Vanda Pharmaceuticals

Chief Executive Officer

2015

Thomas Gibbs

Vanda Pharmaceuticals

Former Senior Vice President, Chief Commercial Officer

2015

Paolo Baroldi

Vanda Pharmaceuticals

Chief Medical Officer

News

You may also like